Exec Summary > Updated: 15/06/25 Anne Wojcicki, co-founder and former CEO of 23andMe, is set to regain control of the genetic testing...

Exec Summary The Nelson Advisors team regularly advise and mentor students, guest lecture and speak at leading University Business...

Exec Summary Yes, there’s often too much focus on potential synergies, particularly tied to technology and team, in healthcare mergers...

Exec Summary: Updated 15/04/25 The closure of NHS England introduces both risks and opportunities for healthcare technology and...

Digital Health Rewired 2025: 10 Key Talking Points Exec Summary Digital Health Rewired 2025, is taking place on March 18-19 th at the NEC...

Exec Summary The Nelson Advisors team examines a range of high potential market segments in the UK for Future Health Intelligence...

Exec Summary A search fund is an investment vehicle designed to support an entrepreneur (or a small team of entrepreneurs) in...

Exec Summary The healthcare cybersecurity landscape is evolving rapidly, driven by increasing cyber threats, regulatory pressures, and...

Exec Summary In 2025, AI healthcare companies attracting funding and acquisitions reflect a mix of cutting-edge innovation and practical...

Exec Summary: The HealthTech M&A landscape in 2025 is characterised by a mix of opportunity and caution. While innovative technologies...

Nelson Advisors partner Lloyd Price has been invited to Judge the HealthInvestor 2025 Awards for the second year in a row and third time...

Exec Summary: DeepSeek R1 is a powerful language model that has been trained using a novel reinforcement learning approach. This approach...

Exec Summary: Looking ahead into 2025, the UK HealthTech market is on track to continue growing and evolving around four main themes,...

Exec Summary: The intersection of neuroscience and technology has given rise to a groundbreaking field known as Brain-Computer Interfaces...

The IPO landscape for HealthTech startups in 2025 is likely to be dynamic, influenced by various factors such as market conditions, company performance and regulatory changes. While it's challenging to predict with certainty which specific companies will go public, the following six HealthTech startups have the potential to be among the IPO candidates: Omada Health, Hinge Health, Sword Health, Doctolib, Aledade, Quantum Health